Global burden of hepatitis C: considerations for healthcare providers in the United States

An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalen...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical infectious diseases Vol. 55 Suppl 1; p. S10
Main Authors:	Averhoff, Francisco M, Glass, Nancy, Holtzman, Deborah
Format:	Journal Article
Language:	English
Published:	United States 15.07.2012
Subjects:	Disease Eradication - methods Global Health Health Personnel - organization & administration Health Personnel - standards Hepacivirus - pathogenicity Hepatitis C - blood Hepatitis C - epidemiology Hepatitis C - prevention & control Hepatitis C - virology Humans Liver Cirrhosis - epidemiology Liver Cirrhosis - prevention & control Liver Cirrhosis - virology Liver Neoplasms - epidemiology Liver Neoplasms - prevention & control Liver Neoplasms - virology Prevalence Preventive Health Services - organization & administration Preventive Health Services - standards Risk Factors United States - epidemiology Viral Load United States
ISSN:	1537-6591, 1537-6591
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs.
AbstractList	An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs.An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs. An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%. In contrast to the United States and other developed countries, HCV transmission in developing countries frequently results from exposure to infected blood in healthcare and community settings. Hepatitis C prevention, care, and treatment programs must recognize country-specific epidemiology, which varies by setting and level of economic development. Awareness of the global epidemiology of HCV infection is important for US healthcare providers treating foreign-born patients from countries where HCV infection is endemic and for counseling patients who travel to these countries. Countries with a high burden of HCV infection also would benefit from establishing comprehensive prevention, care, and treatment programs.
Author	Averhoff, Francisco M Glass, Nancy Holtzman, Deborah
Author_xml	– sequence: 1 givenname: Francisco M surname: Averhoff fullname: Averhoff, Francisco M email: fma0@cdc.gov organization: Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA. fma0@cdc.gov – sequence: 2 givenname: Nancy surname: Glass fullname: Glass, Nancy – sequence: 3 givenname: Deborah surname: Holtzman fullname: Holtzman, Deborah
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/22715208$$D View this record in MEDLINE/PubMed
BookMark	eNpNUE1LAzEQDVKxtnrxB0iOXlbzsdvsepOiVSh40F68LPmY0Mg2qUlW8N8bsYKHYd7MezzezAxNfPCA0AUl15R0_EY7UyrxBT1Cp7Tholo0HZ38w1M0S-mdEEpb0pygKWOCNoy0p-htNQQlB6zGaMDjYPEW9jK77BJe3mIdfHIGYtkUhG2IhZdD3moZAe9j-PxhE3Ye5y3gjXcZDH7JMkM6Q8dWDgnOD32ONg_3r8vHav28elrerStd8y5XtSSitlZSzeu2DFpATYxpDaMd2E7VjZBCWc5VA5xTowkTQFRnBTFdbYDN0dWvb4nzMULK_c4lDcMgPYQx9ZQUJyHK5UV6eZCOagem30e3k_Gr__sH-waE5mRd
CitedBy_id	crossref_primary_10_1371_journal_ppat_1008021 crossref_primary_10_1017_S1461145713000266 crossref_primary_10_1007_s10900_019_00680_3 crossref_primary_10_1016_j_bmcl_2017_01_089 crossref_primary_10_1016_j_jcv_2018_02_016 crossref_primary_10_1080_10826076_2017_1298526 crossref_primary_10_17795_iji_36642 crossref_primary_10_1007_s13318_017_0451_9 crossref_primary_10_1371_journal_pone_0087564 crossref_primary_10_1371_journal_pone_0145530 crossref_primary_10_1111_jvh_12725 crossref_primary_10_1016_j_bbamcr_2023_119536 crossref_primary_10_1016_j_drugpo_2015_07_004 crossref_primary_10_3892_etm_2019_7995 crossref_primary_10_1093_ofid_ofz318 crossref_primary_10_3390_ma14123318 crossref_primary_10_4103_ejim_ejim_41_19 crossref_primary_10_1128_JVI_02156_15 crossref_primary_10_3390_antibiotics11121838 crossref_primary_10_3322_caac_21335 crossref_primary_10_1016_j_jbiotec_2016_10_022 crossref_primary_10_5812_hepatmon_134406 crossref_primary_10_3390_pathophysiology29030024 crossref_primary_10_1177_0033354918774788 crossref_primary_10_1177_0263276417727058 crossref_primary_10_1186_s13104_015_1253_2 crossref_primary_10_1186_s12954_017_0156_z crossref_primary_10_1111_hpb_12128 crossref_primary_10_1371_journal_pone_0228351 crossref_primary_10_3390_tropicalmed7020014 crossref_primary_10_1080_23120053_2017_1349065 crossref_primary_10_1111_jcpt_12467 crossref_primary_10_1155_2017_5841272 crossref_primary_10_1080_15321819_2020_1814810 crossref_primary_10_1016_j_apjtm_2016_07_031 crossref_primary_10_1080_15332640_2018_1425950 crossref_primary_10_2217_fvl_14_89 crossref_primary_10_1097_MOT_0b013e32835a7d3a crossref_primary_10_3748_wjg_v21_i42_11984 crossref_primary_10_1002_rmv_2320 crossref_primary_10_1093_cid_ciu965 crossref_primary_10_1155_2014_628683 crossref_primary_10_1186_s13643_016_0293_6 crossref_primary_10_1007_s13365_016_0494_8 crossref_primary_10_1155_2014_827849 crossref_primary_10_1155_2022_9199190 crossref_primary_10_1111_trf_12297 crossref_primary_10_1007_s12072_014_9559_z crossref_primary_10_1177_1060028015592015 crossref_primary_10_1007_s10995_023_03666_9 crossref_primary_10_1016_j_antiviral_2017_12_004 crossref_primary_10_5812_hepatmon_10236 crossref_primary_10_1007_s10389_016_0725_8 crossref_primary_10_1007_s00261_022_03651_w crossref_primary_10_1080_14740338_2017_1325869 crossref_primary_10_1111_jvh_12504 crossref_primary_10_3748_wjg_v24_i12_1299 crossref_primary_10_5812_hepatmon_83337 crossref_primary_10_3748_wjg_v21_i43_12510 crossref_primary_10_1111_jgh_13995 crossref_primary_10_5372_1905_7415_0804_313 crossref_primary_10_1016_j_drugalcdep_2015_03_039 crossref_primary_10_1371_journal_pone_0303314 crossref_primary_10_1097_MEG_0000000000000647 crossref_primary_10_1016_j_antiviral_2015_11_011 crossref_primary_10_1016_j_clinre_2016_05_012 crossref_primary_10_1371_journal_pone_0184127 crossref_primary_10_1074_jbc_M114_613653 crossref_primary_10_1158_1078_0432_CCR_12_0928 crossref_primary_10_1016_j_hjb_2017_04_002 crossref_primary_10_1016_j_mgene_2015_04_004 crossref_primary_10_1097_MCG_0000000000000400 crossref_primary_10_1186_s12879_016_1845_z crossref_primary_10_1089_vim_2016_0144 crossref_primary_10_1016_S2221_1691_15_30004_6 crossref_primary_10_1097_MCG_0000000000000489 crossref_primary_10_1177_2050312119900870 crossref_primary_10_1111_jvh_12516 crossref_primary_10_7448_IAS_19_1_20659 crossref_primary_10_1002_jmv_24211 crossref_primary_10_1007_s10238_014_0297_2 crossref_primary_10_1155_2021_6615008 crossref_primary_10_1016_j_canlet_2013_06_028 crossref_primary_10_1097_MEG_0000000000000773 crossref_primary_10_5604_01_3001_0010_7534 crossref_primary_10_1016_j_cgh_2015_08_015 crossref_primary_10_1111_imr_12671 crossref_primary_10_1186_s12985_018_1060_1 crossref_primary_10_5114_amscd_2019_86739 crossref_primary_10_1128_JVI_00194_17 crossref_primary_10_1007_s13546_012_0529_y crossref_primary_10_1128_JVI_00970_14 crossref_primary_10_1100_2012_580216 crossref_primary_10_1186_s12879_016_1708_7 crossref_primary_10_1016_j_jinf_2020_06_025 crossref_primary_10_3748_wjg_v21_i35_10224 crossref_primary_10_5812_jkums_99337 crossref_primary_10_1099_jgv_0_000608 crossref_primary_10_1111_liv_12964 crossref_primary_10_1080_14656566_2017_1282459 crossref_primary_10_1371_journal_pone_0291994 crossref_primary_10_1016_j_meegid_2015_02_022 crossref_primary_10_1016_j_otc_2018_01_011 crossref_primary_10_1093_eurpub_cky142 crossref_primary_10_17816_EID40836 crossref_primary_10_1155_2016_8372835 crossref_primary_10_1186_s12876_015_0320_4 crossref_primary_10_1111_jhn_12503 crossref_primary_10_1186_s12913_015_0746_y crossref_primary_10_5812_iji_41216 crossref_primary_10_1007_s40121_017_0146_1 crossref_primary_10_1007_s10517_016_3210_z crossref_primary_10_4254_wjh_v10_i10_743 crossref_primary_10_1128_AAC_00223_15 crossref_primary_10_1155_2015_414207 crossref_primary_10_7717_peerj_2576 crossref_primary_10_3390_cells8030252 crossref_primary_10_5812_hepatmon_8104 crossref_primary_10_1371_journal_pone_0160450 crossref_primary_10_1186_s12879_015_1135_1 crossref_primary_10_1038_s41578_023_00625_2 crossref_primary_10_1097_MEG_0000000000000588 crossref_primary_10_1016_j_jviromet_2014_03_012 crossref_primary_10_1007_s10900_024_01339_4 crossref_primary_10_1002_jmv_23897 crossref_primary_10_1016_j_antiviral_2015_01_004 crossref_primary_10_1186_s12889_016_3671_z crossref_primary_10_1111_liv_12063 crossref_primary_10_4254_wjh_v6_i12_916 crossref_primary_10_3748_wjg_v20_i42_15476 crossref_primary_10_1007_s10865_016_9778_y crossref_primary_10_1111_jvh_12656 crossref_primary_10_1186_s12884_024_06714_6 crossref_primary_10_1111_tmi_12688 crossref_primary_10_1155_2015_287640 crossref_primary_10_1007_s00784_014_1261_y crossref_primary_10_3390_jcm9041030 crossref_primary_10_1097_MD_0000000000029620 crossref_primary_10_1590_1519_6984_244977 crossref_primary_10_1007_s10096_017_2995_7 crossref_primary_10_1016_j_dld_2016_07_014 crossref_primary_10_3748_wjg_v28_i22_2417 crossref_primary_10_1002_jmv_24912 crossref_primary_10_1007_s00228_016_2025_1 crossref_primary_10_1007_s12553_019_00405_5 crossref_primary_10_1038_cmi_2014_127 crossref_primary_10_1128_JVI_02119_13 crossref_primary_10_1002_cncr_31869 crossref_primary_10_1186_s13104_020_05313_w crossref_primary_10_1039_C5CS00287G crossref_primary_10_2196_resprot_7936 crossref_primary_10_1002_rmv_1953 crossref_primary_10_1371_journal_pone_0151946 crossref_primary_10_1097_MOT_0b013e32835a2b5a crossref_primary_10_1111_hepr_12173 crossref_primary_10_1007_s11096_018_0628_6 crossref_primary_10_1002_jmv_23554 crossref_primary_10_1007_s12072_018_9861_2 crossref_primary_10_1016_j_ejmech_2016_06_041 crossref_primary_10_1002_phar_1700 crossref_primary_10_1007_s11096_015_0144_x crossref_primary_10_1016_j_proche_2016_01_028 crossref_primary_10_17795_iji_39008 crossref_primary_10_1080_09540121_2014_906549 crossref_primary_10_1099_vir_0_065094_0 crossref_primary_10_1371_journal_pone_0067756 crossref_primary_10_1007_s15010_016_0975_y crossref_primary_10_1097_MD_0000000000041793 crossref_primary_10_1179_2049396713Y_0000000042 crossref_primary_10_1586_ecp_13_18 crossref_primary_10_1007_s10903_017_0652_y crossref_primary_10_1128_JVI_03523_12 crossref_primary_10_4254_wjh_v8_i2_107 crossref_primary_10_5604_01_3001_0011_7391 crossref_primary_10_1016_j_cmpb_2016_11_012 crossref_primary_10_1080_10826068_2019_1689509 crossref_primary_10_1016_j_jhin_2016_01_013 crossref_primary_10_1586_epr_12_47 crossref_primary_10_1155_2017_3268650 crossref_primary_10_1177_1553350613505713
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1093/cid/cis361
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1537-6591
ExternalDocumentID	22715208
Genre	Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	United States
GeographicLocations_xml	– name: United States
GroupedDBID	--- ..I .2P .GJ .I3 .ZR 08P 0R~ 1KJ 1TH 29B 2AX 2WC 36B 3O- 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 70D AABZA AACGO AACZT AAJKP AAJQQ AAMVS AANCE AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAYOK ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNGD ABNHQ ABNKS ABOCM ABPLY ABPQP ABPTD ABQLI ABQNK ABSMQ ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACFRR ACGFO ACGFS ACHIC ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFQV AFFZL AFIYH AFOFC AFRAH AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APJGH APWMN AQDSO AQKUS AQVQM ASPBG ATGXG AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BZKNY C1A C45 CDBKE CGR CS3 CUY CVF CZ4 DAKXR DCCCD DIK DILTD DU5 D~K E3Z EBS ECM EE~ EIF EIHJH EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HQ3 HTVGU HVGLF HW0 HZ~ IOX IPSME J21 J5H JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KSI KSN L7B M49 MBLQV MHKGH MJL ML0 N4W N9A NGC NOMLY NOYVH NPM NU- NVLIB O0~ O9- OAUYM OAWHX OBFPC OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 VH1 W8F X7H Y6R YAYTL YKOAZ YXANX ZGI ~91 ~S- 7X8 AJBYB
ID	FETCH-LOGICAL-c439t-4a074ffa1c3484a0c7e40dd8d219ef9b457a7bf33b5e331dc027e0b9f70d94de2
IEDL.DBID	7X8
ISICitedReferencesCount	227
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000305613400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1537-6591
IngestDate	Thu Oct 02 05:56:37 EDT 2025 Thu Apr 03 07:02:24 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c439t-4a074ffa1c3484a0c7e40dd8d219ef9b457a7bf33b5e331dc027e0b9f70d94de2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://academic.oup.com/cid/article-pdf/55/suppl_1/S10/20910760/cis361.pdf
PMID	22715208
PQID	1021977805
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1021977805 pubmed_primary_22715208
PublicationCentury	2000
PublicationDate	2012-07-15
PublicationDateYYYYMMDD	2012-07-15
PublicationDate_xml	– month: 07 year: 2012 text: 2012-07-15 day: 15
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Clinical infectious diseases
PublicationTitleAlternate	Clin Infect Dis
PublicationYear	2012
SSID	ssj0011805
Score	2.5226045
Snippet	An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including... An estimated 2%-3% of the world's population is living with hepatitis C virus (HCV) infection, and each year, >350 000 die of HCV-related conditions, including...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	S10
SubjectTerms	Disease Eradication - methods Global Health Health Personnel - organization & administration Health Personnel - standards Hepacivirus - pathogenicity Hepatitis C - blood Hepatitis C - epidemiology Hepatitis C - prevention & control Hepatitis C - virology Humans Liver Cirrhosis - epidemiology Liver Cirrhosis - prevention & control Liver Cirrhosis - virology Liver Neoplasms - epidemiology Liver Neoplasms - prevention & control Liver Neoplasms - virology Prevalence Preventive Health Services - organization & administration Preventive Health Services - standards Risk Factors United States - epidemiology Viral Load
Title	Global burden of hepatitis C: considerations for healthcare providers in the United States
URI	https://www.ncbi.nlm.nih.gov/pubmed/22715208 https://www.proquest.com/docview/1021977805
Volume	55 Suppl 1
WOSCitedRecordID	wos000305613400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3LS8MwGMCDOhEvvh_zRQSvYW2TNokXkeHwsrGDwvBS8mS7tNNO_36_9OFOguCltIdA--VL8uv3ROgu5sKZKHFEGmYInFAm3CmiVAbwrHikua2bTfDJRMxmctoa3Ko2rLLbE-uN2pYm2MgHoQU1sIqI0oflOwldo4J3tW2hsYl6FFAmaDWfrb0IsahDGGFRc5KlMu7Kk0o6MDDVZlHRLP4dLesjZrT_35c7QHstXOLHRhsO0YYrjtDOuHWfH6O3psI_1nXuAi49nrsQUb1aVHh4j03bvLMx4mHAWTz_CQ_DXc5ehRcFBmzEDa7iBldP0Ovo6WX4TNrmCsQAg6wIUwAP3qvYUCbgwXDHImuFhS9xXmqWcsW1p1SnjtLYwoRyF2npeWQlsy45RVtFWbhzhHUaElZtIoWzzHALP0nea2tZZmQoV9ZHt53UclDe4JFQhSs_q3wttz46a0SfL5sqG3mScGCLSFz8YfQl2gWQqcNo4_QK9TwsXXeNts0XCPDjptYKuE6m4284YcO6
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+burden+of+hepatitis+C%3A+considerations+for+healthcare+providers+in+the+United+States&rft.jtitle=Clinical+infectious+diseases&rft.au=Averhoff%2C+Francisco+M&rft.au=Glass%2C+Nancy&rft.au=Holtzman%2C+Deborah&rft.date=2012-07-15&rft.eissn=1537-6591&rft.volume=55+Suppl+1&rft.spage=S10&rft_id=info:doi/10.1093%2Fcid%2Fcis361&rft_id=info%3Apmid%2F22715208&rft_id=info%3Apmid%2F22715208&rft.externalDocID=22715208
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-6591&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-6591&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-6591&client=summon